Discover
ACHV
Achieve Life Sciences, Inc.
6.31
10 x 6.00
11 x 6.75
bid
ask
-
0.19
2.92%
9100 @ 04:53 PM
6.47 +0.16 (2.54%)
| Ytd | 26.96% | |
| 1y | 138.11% |
6.28
day range
6.64
3.60
52 week range
5.59
| Open | 6.47 | Prev Close | 6.50 | Low | 6.28 | High | 6.64 | Mkt Cap | 130.34M |
| Vol | 749.94K | Avg Vol | 125.27K | EPS | -1.12 | P/E | -5.63 | Forward P/E | -3.30 |
| Beta | 1.58 | Short Ratio | 23.98 | Inst. Own | 59.60% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 4.53 | 200-d Avg | 4.66 | 1yr Est | 16.44 |
| Income Statement | |||
| Operating Expenses | 10.46M | ||
| Research and Development Expense | 3.29M | ||
| Selling, General and Administrative Expense | 7.17M | ||
| Operating Income | -10.46M | ||
| Interest Expense | 274.00K | ||
| Net Income | -10.17M | ||
| Net Income Common Stock | -10.17M | ||
| Net Income Common Stock (USD) | -10.17M | ||
| Consolidated Income | -10.17M | ||
| Earnings per Basic Share | -0.19 | ||
| Earnings per Basic Share (USD) | -0.19 | ||
| Earnings per Diluted Share | -0.19 | ||
| Earning Before Interest & Taxes (EBIT) | -9.89M | ||
| Earning Before Interest & Taxes (USD) | -9.89M | ||
| Weighted Average Shares | 53.38M | ||
| Weighted Average Shares Diluted | 53.38M | ||
| Balance Sheet | |||
| Cash and Equivalents | 28.08M | ||
| Cash and Equivalents (USD) | 28.08M | ||
| Investments | 1.19M | ||
| Investments Current | 1.19M | ||
| Current Assets | 31.06M | ||
| Property, Plant & Equipment Net | 49.00K | ||
| Total Assets | 33.10M | ||
| Debt Current | 5.63M | ||
| Total Debt | 14.95M | ||
| Current Liabilities | 11.83M | ||
| Debt Non-Current | 9.32M | ||
| Total Liabilities | 22.43M | ||
| Accumulated Retained Earnings (Deficit) | -270.39M | ||
| Accumulated Other Comprehensive Income | 2.00K | ||
| Shareholders Equity | 10.68M | ||
| Shareholders Equity (USD) | 10.68M | ||
| Assets Non-Current | 2.04M | ||
| Total Debt (USD) | 14.95M | ||
| Goodwill and Intangible Assets | 1.73M | ||
| Liabilities Non-Current | 10.59M | ||
| Trade and Non-Trade Payables | 833.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 57.00K | ||
| Net Cash Flow from Financing | 21.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 7.36M | ||
| Issuance (Purchase) of Equity Shares | 21.00K | ||
| Net Cash Flow from Investing | 14.28M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 14.28M | ||
| Net Cash Flow from Operations | -6.93M | ||
| Effect of Exchange Rate Changes on Cash | -1000 | ||
| Share Based Compensation | -685.00K | ||